(3S,8aS)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)-2-methylhexahydropyrrolo[1,2-a]pyrazin-1(2H)-one

ID: ALA3983466

PubChem CID: 53630920

Max Phase: Preclinical

Molecular Formula: C24H24Cl2FN5O3

Molecular Weight: 520.39

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1C

Standard InChI:  InChI=1S/C24H24Cl2FN5O3/c1-31-13(10-32-7-3-4-18(32)24(31)33)11-35-20-9-17-14(8-19(20)34-2)23(29-12-28-17)30-16-6-5-15(25)21(26)22(16)27/h5-6,8-9,12-13,18H,3-4,7,10-11H2,1-2H3,(H,28,29,30)/t13-,18-/m0/s1

Standard InChI Key:  RPLCLUCJTHAIOW-UGSOOPFHSA-N

Molfile:  

     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   17.4148  -20.2580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2401  -20.2150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6855  -20.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4317  -19.4347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6088  -19.4808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8862  -20.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5093  -20.8654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9577  -21.5575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7828  -21.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1576  -20.7751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7070  -20.0862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0806  -19.3491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9058  -19.3041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3559  -19.9968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1802  -19.9522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5547  -19.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0986  -18.5203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2757  -18.5683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1555  -18.7899    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5272  -18.0518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3797  -19.1685    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   23.6314  -20.6446    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.0395  -20.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2142  -21.0372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7708  -20.3421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0185  -21.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8466  -21.7731    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5697  -21.1175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9439  -20.3847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3626  -19.8024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6291  -20.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7572  -20.9881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2977  -22.4654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6406  -22.5475    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1484  -21.8277    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   21.9813  -20.7335    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  7  1  0
  6  4  1  0
  4  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  6  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  5 19  1  0
 19 20  1  0
 16 21  1  0
 15 22  1  0
  1 23  1  0
 24 23  1  1
 24 25  1  0
 24 27  1  0
 25 29  1  0
 28 26  1  0
 26 27  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 28  1  0
 27 33  1  0
 26 34  2  0
 28 35  1  1
 14 36  1  0
M  END

Associated Targets(Human)

EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHA2 Tclin Ephrin type-A receptor 2 (3499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.39Molecular Weight (Monoisotopic): 519.1240AlogP: 4.51#Rotatable Bonds: 6
Polar Surface Area: 79.82Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.77CX LogP: 4.14CX LogD: 3.62
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.48Np Likeness Score: -0.75

References

1.  (2009)  Receptor-type kinase modulators and methods of use, 

Source